Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Genome-wide maps of ESR2 chromatin state in Mantle cell lymphoma cells

ABSTRACT: Genome-wide maps of ESR2 chromatin state in Mantle cell lymphoma cells

PROVIDER: PRJNA787627 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR17184405.fastq.gz	Fastqsanger.gz
	SRR17184406.fastq.gz	Fastqsanger.gz
	SRR17184407.fastq.gz	Fastqsanger.gz
	SRR17184408.fastq.gz	Fastqsanger.gz
	SRR17184409.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 6

Similar Datasets

Genome-wide maps of ESR2 chromatin state in Mantle cell lymphoma cells

Project description:In order to elucidate chromatin binding regions of ESR2 in Mantle cell lymphoma, we used ESR2 antibodies, opti-mized chromatin-immunoprecipitation (ChIP), and performed ChIP-Seq of ESR2 over-expressed Granta-519 cells and Granta519-mock cells.We present for the first time, the cistrome of nuclear receptor ESR2 in Mantle cell lymphoma cell line.

2022-07-01 | GSE190599 | GEO

Next Generation Sequencing of Mantle cell lymphoma Granta-519 Transcriptomes

Project description:Purpose: The goal of this study is to get a deeper insight of whole transcriptome changes and of signaling pathways involved in eliciting the DPN-mediated effects on Granta-519 tumor progression in vivo. Methods: Mantle cell lymphoma cell line Granta-519 cells were grafted to male NSG mice, followed by treated with ESR2 selective agonist DPN or vehicle. When tumor size reached around 1300 mm3, RNA was extracted with RNeasy Plus Mini Kit (Qiagen) for sequencing. Results: ESR2 selective agonist DPN could inhibit cell adhesion, EMT and angiogenesis in vivo which likely involves regulation of VEGFA, FOS, FOSB, CXCR4, MALAT1 and NEAT1. Conclusions: Our study represents the detailed analysis of Granta-519 transcriptomes in vivo experiment after DPN treatment, with biologic replicates, generated by RNA-seq technology.

2022-07-01 | GSE190600 | GEO

Proteaphagy contributes to bortezomib resistance in mantle cell lymphoma

Project description:TUBE and GST enrichment followed by 1D-gel-LC-MS analysis on cell exract from bortezomib (BTZ)-resistant or sensitive mantle cell lymphoma cells.

2022-02-28 | PXD011867 | Pride

ibrutinib resistance mantle cell lymphoma

Project description:ibrutinib resistance mantle cell lymphoma

| PRJNA593190 | ENA

Tumor biopsies from 71 untreated patients with mantle cell lymphoma

Project description:The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma Keywords: lymphochip; MCL; untreated Tumor biopsies from 71 untreated patients with mantle cell lymphoma

2010-05-23 | E-GEOD-10793 | biostudies-arrayexpress

Gene expression of mantle cell lymphoma-initiating cells from primary tumor samples

2014-08-02 | GSE60023 | GEO

ibrutinib resistance mantle cell lymphoma [Pt_RNA]

Project description:ibrutinib resistance mantle cell lymphoma [Pt_RNA]

| PRJNA593340 | ENA

Expression data for NMD inhibition in Mantle Cell Lymphoma

Project description:Identification of potential tumor suppressor genes using the GINI strategy in Mantle Cell Lymphoma cell lines Keywords: response to drug treatment

2007-12-31 | GSE6728 | GEO

Gene expression of mantle cell lymphoma-initiating cells from primary tumor samples

Project description:In this study we compared the expression of 30215 genes in mantle cell lymphoma-initiating cells (MCL-ICs) with mantle cell lymphoma-non-initiating cells (MCL-non-ICs) and B-cells from healthy donor Three samples each of MCL-ICs and MCL-non-ICs were isolated from aphresis of 3 mantle cell lymphoma primary patient samples and 2 samples of CD19+ Bcells isolated from buffy coats of healthy donor Microarray include both coding and non-coding transcripts but only mRNA coding transcript were included in this study.

2014-08-02 | E-GEOD-60023 | biostudies-arrayexpress

Tumor biopsies from 71 untreated patients with mantle cell lymphoma

2008-04-01 | GSE10793 | GEO